FATE THERAPEUTICS

Details for Australian Trade Mark No. 1341487 (hide)

Owner Fate Therapeutics, Inc.

Convention US 14 May 2009 77737497

Various Convention priority claimed: 14 May 2009, United States of America, No. 77737497 in respect of A FULL LINE OF PHARMACEUTICAL PREPARATIONS AND THERAPEUTIC AGENTS; PHARMACEUTICAL PREPARATIONS AND THERAPEUTIC AGENTS TO MODULATE CELL FATE; REAGENTS FOR RESEAR

Filing Date 10 November 2009

Classes

Class 5 Pharmaceutical preparations and therapeutic agents; pharmaceutical preparations and therapeutic agents to modulate cell fate; reagents for research, drug discovery and development, clinical, and medical use; pharmaceutical preparations and therapeutic agents for the treatment of cancer

Class 42 Medical and clinical research and development in the field of stem cells and small molecule and biologic drug candidates; consulting services in the field of stem cell therapy, disease model systems, and drug discovery and development; medical laboratory, research, pre-clinical, and clinical testing services

Event Publications

11 February 2010 Application filed

25 February 2010 Application Accepted

17 June 2010 Trade Mark Registered/Protected

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

1341488-CONCRIX

1341486-HIGH LEVERAGE NETWORK